Mechanochemically Coupled Multidimensional Modulation of Calcium Overload.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 42411126.
- Also identified by DOI 10.1021/acsnano.6c10419.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Disruption of calcium ion (Ca<sup>2+</sup>) homeostasis has emerged as a promising strategy for tumor therapy. However, the intricate regulation of Ca<sup>2+</sup> signaling and the limitations of single-dimensional modulation often hinder therapeutic efficacy. Here, we developed a Janus nanomotor platform that orchestrates mechanochemically coupled multidimensional modulation of Ca<sup>2+</sup> overload for enhanced tumor therapy. Utilizing a liquid-nano-liquid interface-mediated anisotropic encapsulation strategy, amorphous calcium carbonate (ACC) nanoparticles were asymmetrically coated with mesoporous polydopamine (mPDA) and subsequently functionalized with l-arginine (l-Arg) and hyaluronic acid (HA), forming the Janus ACC@SiO<sub>2</sub>&mPDA-Arg-HA nanomotors that combine structural asymmetry, NO-driven propulsion, and tumor-targeting capability. Within the tumor microenvironment (TME), degradation of the ACC provided a sustained exogenous Ca<sup>2+</sup> reservoir. Simultaneously, the endogenous catalytic conversion of l-Arg into NO triggered self-propulsion, mechanically stimulating the cell membrane to activate Piezo1 channels and promote extracellular Ca<sup>2+</sup> influx. In parallel, NO acted as a gaseous chemical messenger to trigger ryanodine receptors (RyRs)-mediated Ca<sup>2+</sup> release from the endoplasmic reticulum (ER). The mechanically and chemically coupled regulation induces persistent Ca<sup>2+</sup> overload, leading to mitochondrial dysfunction and apoptosis. Our study presents a paradigm of mechanochemical coupling for multidimensional signal modulation, offering a framework for engineering nanomachines that reprogram intracellular signaling in cancer therapy.